Welcome to the Hawaii Chapter of the American College of Cardiology


2026 Conference
Click here to learn about our annual Chapter meeting April 25, 2026
Click here to download the flyer

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • Endometriosis Tied to Higher Long-Term VTE Risk
    Endometriosis was associated with an approximately 50% greater long-term risk of venous thromboembolism (VTE), including higher risks of deep venous thrombosis (DVT) and pulmonary embolism (PE), compared with no endometriosis, according to research published Aug. 8 in the EHJ.
  • Dr. Mohamad Alkhouli Named Editor-in-Chief of JACC: Cardiovascular Interventions
    The ACC has named Mohamad Alkhouli, MD, MBA, FACC, the new editor-in-chief of JACC: Cardiovascular Interventions. Alkhouli brings to the journal an internationally recognized career in interventional cardiology and cardiovascular research, along with more than a decade of editorial leadership experience...
  • TARTAN-HF: NT-proBNP Screening Identifies Undiagnosed HF Among Patients With Diabetes
    A heart failure (HF) screening strategy focused on NT-proBNP identified a large proportion of patients with diabetes who had previously unrecognized but symptomatic HF, according to research published Aug. 19 in JACC.
  • Beyond BMI: Body Composition Patterns Emerge in HF
    Study participants with heart failure (HF), compared with controls, had had more visceral adipose tissue (VAT), more adverse muscle changes and weaker grip strength, according to research published Aug. 6 in JACC: Heart Failure.
  • Vutrisiran Associated With Favorable Changes in Cardiac Parameters, Amyloid Burden
    In patients with transthyretin amyloid cardiomyopathy (ATTR-CM), treatment with vutrisiran is associated with favorable changes in cardiovascular magnetic resonance (CMR) parameters related to cardiac structure, function and amyloid burden, according to a retrospective post hoc analysis of the HELIOS-B trial published Aug. 12 in JAMA Cardiology.